Using light and chlorophyll to destroy tumors

A team of Weizmann Institute of Science researchers is developing an innovative photodynamic approach to destroying tumors. The technique, developed by Prof. Avigdor Scherz of the Department of Plant Sciences and Prof. Yoram Salomon of the Department of Biological Regulation, is based on a non-toxic chemotherapy drug—a water-soluble derivative of the green plant pigment chlorophyll—that is injected into the blood stream or directly into the tumor.

When the drug is illuminated by light in a controlled fashion in the tumor it becomes toxic, destroying tumor blood vessels and cells while having a minimal effect on healthy tissue.

This new, "green" photodynamic material was found to be efficient in curing melanoma with a success rate of 85 percent. It clears from the body faster than the materials used in standard photodynamic therapy, which tend to leave patients with a heightened sensitivity to strong light. This technique is being developed for future therapeutic applications through Yeda.

Related Stories

Photodynamic therapy against cancer

date Feb 09, 2011

In a new study, published in Science Translational Medicine, researchers at the University of Helsinki, Finland, investigated whether eradicating tumor-associated lymphatic vessels and the tumor cells they c ...

Recommended for you

HLA expression tied to penile cancer outcomes

date 4 hours ago

(HealthDay)—Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer, according to a study published in the April issue of The Journal of Urology.

Study points to potential new lung cancer therapy

date 5 hours ago

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.